Introduction

Zhen Wu,Ph.D.

  发布时间: 2016-09-08   信息员:    浏览次数: 887

Zhen WuPh.D.

Professor, Deputy Dean


Experience

Dr. Wu received his Ph.D. in Medicinal Chemistry from Shenyang  Pharmaceutical University in 2004. He is currently Professor of Medicinal  Chemistry of School of Pharmaceutical Sciences Xiamen University. He is an  expert on the State Food and Drug Administration Center for Qualification of  Licensed Pharmacist. He is invited to be an Editorial Board Member of Strait  Pharmaceutical Journal in 2012. His lab is currently funded by the National  Natural Science Foundation of China, National Science and Technology Major  Project, and 863 Project.


Research

Synthetic Medicinal Chemistry,  Natural Product Chemistry and Chemical Biology;


Zhen lab’s primary research  interests are the discovery and development of novel pharmaceuticals. His lab is  also interested in designing chemical probes to study gene regulation. His  research program focuses on the design and synthesis of novel RXRα-targeting  agents for the future  development of an improved clinical agent within this class of cancer  chemotherapeutic agents.


Zhen’s lab has been studying the  isolation, structural elucidation and the anti-tumor activity of secondary  metabolites from deep-sea environmental metagenomic libraries clones. One focus  of his research program is to obtain new functional gene clusters and lead  compounds through the discovery of new clone secondary metabolic processes by  using both the sequenced genomes of cultured clones and the new secondary  metabolites. They are currently using this approach for biosynthetic pathways to  develop new anti-tumor drugs.


Selected  Publications:last 5 years

Hong-Ming Cheng,  Ying-Kun Qiu, Zhen Wu, Yu-Fen Zhao DNA damage induced by Shikonin in the  presence of Cu(II) ions: Potential mechanism of its activity to apoptotic cell  death, J Asian Natur product Res 2011131):12-19

Xiang Gao, Weizhu  Chen, Gangtian Zhu, Ruizao Yi, Zhen Wu, Pengxiang Xu,Yufen Zhao Fast separation  of antiviral nucleoside phosphoramidate and H-phosphonate diastereoisomers by  reversed-phase liquid chromatography, Journal of Chromatography A  201112181416–1422

Lin Chen, Xi-  Xiang Tang, Min zheng, Zhi-Wei Yi, Ying-Kun Qiu, Zhen Wu, A novel indole  alkaloid from deep-sea sediment metagenomic clone derived Escherichia coli  fermentation broth,J Asian Natur  product Res 201113(5):444-448

MeiXiang Zhu,  Yanbing Gao, Zhen Wu, YuFen ZhaoA rapid  HPLC/ESI-MS/MS method for quantitative analysis of isovalerylshikonin in rat  plasma, Biomedical Chromatography. 2010, 24(4):413-419

Hu-Yi Zhao ,  Fu-Kai Wu , Ying-Kun Qiu, Zhen Wu , Yong-Tao Jiang , Ji-Yong Chen Studies on cytotoxic constituents from skin of  the toad Bufo bufo gargariansJ Asian Natur product Res 2010,129):793-800.

Meixiang Zhu,  BaoYing Xie, Guo Tang, Anfu Hu, Meijuan Fang, Zhen Wu, Yufen Zhao. Quantitative  determination of five zidovudine pro-drugs of diaryl phosphate triesters in rat  plasma by high-performance liquid chromatography-electrospray ionization tandem  mass spectrometry, J Pharm Biomed Anal 2008, 485):1417-1424


Tel: +86-592-218-2976

Fax: +86-592-218-1879

Email:  wuzhen@xmu.edu.cn


Copyright©2011 School of Pharmaceutical Sciences Xiamen University All Rights Reserved